SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022-RB]
GTX01556
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
TargetS
Overview
- SupplierGeneTex
- Product NameSARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [CR3022-RB]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds the amino acids 318-510 in the S1 domain of the SARS-CoV Spike protein as well as SARS-CoV-2 (COVID-19) Spike protein. The antibody also binds to P462L-substituted S318-510 fragments of the SARS spike protein. The binding epitope is on
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDCR3022-RB
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID1489668
- Target nameS
- Target descriptionspike glycoprotein
- Target synonymsE2; sars2; spike glycoprotein
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction2°C to 8°C,-20°C or -80°C
- UNSPSC12352203
References
- Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice. Lin HT et al., 2021 Dec 15, Int J Biol MacromolRead more
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Tian X et al., 2020, Emerg Microbes InfectRead more
- Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. ter Meulen J et al., 2006 Jul, PLoS MedRead more